Home › Steatotic Liver Disease › Illinois
Pag-aaral pangklinika para sa Steatotic Liver Disease sa Illinois
6 pag-aaral para sa Steatotic Liver Disease ang naghahanap ng mga kalahok sa mga site sa Illinois.
Mga Lungsod sa Illinois
Opisyal na teksto ng pag-aaral (English)
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Chicago
- 89bio Clinical Study Site, Glenview
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06419374A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Chicago
Nagre-recruitPhase 3
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06318169A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- University of Chicago Medical Center, Chicago
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07165028A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Akero Clinical Study Site, Chicago
Nagre-recruitPhase 3
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT06528314Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
- RUSH University Medical Center, Chicago
Nagre-recruit
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update May 19, 2026 · NCT04054310Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease
- Ann & Robert H Lurie Children's Hospital of Chicago, Chicago
Nagre-recruitPhase 2
Edad 16 hanggang 20 · Lahat ng kasarian · Na-update Ene 21, 2026 · NCT06355310Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.